[18F]DPA-714 PET imaging: a new tool to reveal the hidden part of focal drug-resistant epilepsy?

[¹⁸F]DPA-714 PET imaging: a new tool to reveal the hidden part of focal drug-resistant epilepsy?

Acta Neurol Belg. 2023 Apr;123(2):757-759. doi: 10.1007/s13760-022-02079-9. Epub 2022 Sep 9.

Margaux Cheval^{1

2}, Sebastian Rodrigo³, Ana Maria Petrescu⁴, Claire Leroy³, Viviane Bouilleret^{4

3}

¹ Neurophysiology and Epileptology Department, Hôpital Bicêtre, Assistance Publique des Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires Paris-Sud, Le Kremlin-Bicêtre, France. margaux.cheval@aphp.fr.
² Laboratoire d'Imagerie Biomédicale Multimodale (BioMaps), Université Paris-Saclay, CEA, CNRS, Inserm, Service Hospitalier Frédéric Joliot, Orsay, France. margaux.cheval@aphp.fr.
³ Laboratoire d'Imagerie Biomédicale Multimodale (BioMaps), Université Paris-Saclay, CEA, CNRS, Inserm, Service Hospitalier Frédéric Joliot, Orsay, France.
⁴ Neurophysiology and Epileptology Department, Hôpital Bicêtre, Assistance Publique des Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires Paris-Sud, Le Kremlin-Bicêtre, France.

No abstract available

Keywords: Drug-resistant focal epilepsy; Epilepsy surgery; Presurgical evaluation; TSPO; [18F]DPA-714 PET imaging.

N,N-diethyl-2-(2-(4-(2-fluoroethoxy)phenyl)-5,7-dimethylpyrazolo(1,5-a)pyrimidin-3-yl)acetamide
Pyrazoles